share_log

JP Morgan Maintains Overweight on IDEXX Laboratories, Raises Price Target to $600

Benzinga ·  Aug 2, 2023 13:20

JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $550 to $600.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment